ProfileGDS5822 / ILMN_1247553
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 93% 95% 92% 93% 94% 95% 91% 92% 94% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1833.493
GSM1276600PDAC Late Ablation Control 2117095
GSM1276601PDAC Late Ablation Control 3821.992
GSM1276602PDAC Late Ablation 1742.993
GSM1276603PDAC Late Ablation 21009.494
GSM1276604PDAC Late Ablation 31295.495
GSM1303940PDAC Late Ablation_anti-CTLA4 1557.991
GSM1303941PDAC Late Ablation_anti-CTLA4 2841.592
GSM1303942PDAC Late Ablation_anti-CTLA4 31010.794